CDK5 and Alzheimer disease: Similarly, increased concentrations of SNO-Cdk5 have been observed in postmortem AD brains compared to control human brains, suggesting that S-nitrosylation of Cdk5 disturbs its enzymatic activity contributing to AD pathophysiology [390].